ALERT: Supreme Court Enters Abortion Pill Battle

( – BREAKING NOW: Just moments ago, the U.S. Supreme Court temporarily halted a lower court’s decision that revoked the FDA’s approval for a widely-used abortion pill.

Justice Alito issued a brief pause on U.S. District Judge Kacsmaryk’s ruling concerning the distribution of mifepristone, one of two drugs typically used in a chemical abortion procedure.

Mifepristone, a substance that blocks progesterone, ends the unborn child’s life by depriving it of essential nutrients, while misoprostol induces contractions to empty the uterus. Together, these drugs account for over half of all abortions in the U.S.

This temporary hold will remain in effect until 11:59 p.m. ET on Wednesday.

Following Judge Kacsmaryk’s decision, the Department of Justice appealed the case, which has now been brought to the Supreme Court.

The judge’s injunction reversed the FDA’s approval of mifepristone in 2000 but did not completely withdraw or suspend the drug’s approval despite opposition from pro-life groups. A contrasting decision from a federal judge in Washington State soon followed this ruling.

Judge Kacsmaryk wrote in his 67-page opinion, “The Court does not second-guess FDA’s decision-making lightly. But here, FDA acquiesced on its legitimate safety concerns — in violation of its statutory duty — based on plainly unsound reasoning and studies that did not support its conclusions.”

The lawsuit that led to this case was filed in November by Alliance Defending Freedom on behalf of the Alliance for Hippocratic Medicine, a group of pro-life medical organizations, and four pro-life doctors.

The plaintiffs argued that the FDA neglected to perform an extensive safety assessment of the drug before granting its approval nearly 25 years ago.

They claimed that the FDA should have increased oversight of the drugs rather than removing existing safeguards and making the drug more easily accessible.